Treatment Quick search: Lipids | Atherosclerosis | Diagnosis
Statin
Rosuvastatin
Efficacy
Safety and Tolerability
Controlled Trials
Post Marketing Surveillance
Pharmacoepidemiology
Clinical Research
Fibrates
Bile Acid Sequestrants
Nicotinic Acid (Niacin)
Diet and Exercise
References

Safety and Tolerability

AstraZeneca is committed to ensuring that CRESTOR™ provides safe and effective treatment for patients

To support this and demonstrate our commitment to you and your patients, we have adopted an industry-leading approach in conducting a comprehensive post-marketing evaluation of CRESTOR™.

We'd now like to take the opportunity to share some of the recent results with you.

The overall safety programme consists of three elements: 

  1. Controlled clinical trial data
  2. Post marketing surveillance in over 7 million patients worldwide
  3. Pharmacoepidemiology studies conducted in four markets

 

^ Top
 
Please Log in
Free registration to access disease diagnosis, patient management, physician tools.

Only registered users have access to this content.

Already Registered?

Email    Password   

Not a member?

Don't worry, registration is quick and FREE! We welcome all Healthcare professionals, doctors, nurses and medical students. 

Register today to have full access to a wealth of drug data, educational and evidence based interactive guides across all major theraputic areas, disease management, and clinical tools.

As a practicing Healthcare professional, you can also opt-in to join our market research panel – www.epgsurvey.com – and get paid for sharing your expert clinical opinions!

REGISTER today it only takes a minute! and it's FREE

Having problems?

Use our forgotten password facility or email us at: contact@epgonline.org

Exit Log in